Bioterror brain drain: infectious-disease specialists are following the big bucks to Washington's new multibillion-dollar program on bioterrorism research--but at what human cost?
American Prospect, The, October, 2003 by Goozner, Merrill
 | Content provided in partnership with |  |
DR. MARCUS HORWITZ, PROFESSOR OF MEDICINE AT THE University of California, Los Angeles, has devoted most of his career to finding a vaccine for tuberculosis. Though the age-old killer is well controlled in the industrialized world, TB kills more than 2 million people each year among the global poor.
- Most Popular Articles in News
- The Ten Best Laptop bags
- Tata plans cheapest-ever car for Indian market
- GLOBALIZATION AND THE DEVELOPMENT OF UNDERDEVELOPMENT OF THE THIRD WORLD
- Corn is good for you; Corn is not only a tasty treat, but also a cereal that ...
- THE 50 BEST STYLISH HANDBAGS TO CARRY
- More »
It's not a sexy field: Compared with funding for heart-disease, HIV/AIDS or cancer research, National Institutes of Health money for TB research is a minor blip. Applied research into potential TB cures and vaccines is not a priority for the agency, or for drug companies, which see no ...
Read the rest of this article with a Free Trial at HighBeam Research.